Stocktoria

YD Bio Ltd YDES

Nasdaq · stock · Services-Medical Laboratories · website · IPO 2025-08-29

YD Bio Ltd statistics & valuation

Market cap$188.4M
Net margin-1392.6%
FCF margin-1346.6%
Return on capital-43.4%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-276.60% -1392.60% 20242025
Gross margin (%)
30.40% 28.10% 20242025
Operating margin (%)
-286.50% -883.30% 20242025
Return on equity (%)
-21.40% 20242025
Shares outstanding
64.7M 70.8M 20242025
Net debt ($)
20242025
Share buybacks ($)
20242025
Return on assets (%)
-20.60% -60.30% 20242025
Free cash flow margin (%)
-254.30% -1346.60% 20242025
Debt / equity (×)
20242025
EPS ($)
-$0.02 -$0.12 20242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024
Gross margin28.1%30.4%
Operating margin-883.3%-286.5%
Net margin-1392.6%-276.6%
FCF margin-1346.6%-254.3%
Return on assets-60.3%-20.6%
Return on equity291.0%-21.4%
Current ratio5.8813.18

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.